Regen BioPharma (RGBPP) Stock Highlights

0.58 | +0%

2024-07-04 05:04:28

Regen BioPharma Inc is an us-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The companys principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.

Statistics

Range Today

0.58 0.58

Volume Today 561

Range 1 Year

0.2 5.75

Volume 1 Year 56.2K

Range 3 Year

null 582.6

Volume 3 Year 11.25M

Range 10 Year

null 900

Volume 10 Year 11.69M

Highlights

Market Capitalization 44.79M (micro)

Floating Shares 4.11M

Current Price 0.58

Price To Earnings -70.59

Price To Revenue 28.69

Earnings Per Share -0.02

Performance

Latest 0%

1 Month -67.05%

3 Months -81.88%

6 Months -75.42%

1 Year -88.4%

3 Years -99.47%

5 Years -96.91%

10 Years -96.13%

Benchmarks

Market Capitalization

253 / 368

Gross Profits

141 / 278

Total Revenue

268 / 300

Total Rank

245 / 368

Free Cashflow

49 / 352

Performance 5 years

317 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.